Skip to content
Finance Investment

New research shows Aussies should lean on technology as tax deadline approaches

Intuit Quickbooks < 1 min read

As we approach the deadline for lodging your own tax return on the 31 October, new data by Intuit QuickBooks shows Australians should consider leaning on accountants as their technology will support growth and improve processes.

The research shows 3 in 4 (79%) Australian accountants agree that outsourcing is a leading way to maintain business growth and advisory services, with 99.6% using AI over the past 12 months to support client success.

Accountants have used technology such as AI in the past 12 months to support clients with:

  • Data entry and processing (62%)

  • Fraud detection and prevention (51%)

  • Real-time financial insights (47%).

Alan FitzGerald the founder of technology advisory specialists Practice Connections Advisory says, “the greatest benefit of AI for the accounting industry has been the democratisation of the technology which gives all bookkeepers and accountants access to software, previously only available to larger firms. Sadly, the general message is that AI will replace accountants. However, clients demand human interaction. In our role as translators, accountants should leverage AI to streamline processes, so they can focus their time on clients and anxiety transfer.”

We can offer you an interview with:

  • Damien Greathead, Head of Accounting at Intuit QuickBooks Australia, to speak to the new research.

For more tips, visit https://quickbooks.intuit.com/au/blog/ 

For more information, contact Carla Franz [email protected]

 

More from this category

  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:
  • Environment, Finance Investment
  • 17/03/2026
  • 10:21
HESTA

HESTA launches search for Australia’s early childhood education champions

17 March 2026 The search for Australia’s most outstanding early childhood educators is underway with nominations opening today for the 2026 HESTA Early Childhood…

  • Contains:
  • Finance Investment, Oil Mining Resources
  • 17/03/2026
  • 09:57
Jane Morgan Management

Moab to acquire additional uranium tenements at Manyoni Project in Tanzania

Perth, Australia – 17 March 2026 Moab Minerals Limited (ASX: MOM) has strengthened its position at the Manyoni Uranium Project in Tanzania after securing the transfer of four uranium tenements adjacent to the project area from AuKing Limited (ASX: AKN). The tenements have been transferred to Moab’s Tanzanian subsidiary, Katika Resources Limited, and expand the Company’s exploration footprint across a prospective palaeochannel uranium system already mineralised at Manyoni. The acquisition forms part of Moab’s strategy to consolidate a strategic uranium landholding in central Tanzania and advance exploration across multiple targets associated with the broader palaeo-drainage system. Historical drilling across the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.